pharma · Nonalcoholic Steatohepatitis
Tobira Therapeutics
Tobira Therapeutics is a pharma organization headquartered in CN. Primary therapeutic focus areas include Nonalcoholic Steatohepatitis. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Placebo
Phase 3 · small molecule · Nonalcoholic Steatohepatitis
Placebo for Nonalcoholic Steatohepatitis is a Phase 3 program (small_molecule) at Tobira Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code 3152-301-002
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Tobira Therapeutics
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Nonalcoholic Steatohepatitis
- Status
- terminated
- Trials
- 1